Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5cfa1c96e066239cfd1819e513f6003 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate |
2016-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be3caa9538ca3031d48a8362850782ce |
publicationDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017231973-A1 |
titleOfInvention |
Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases |
abstract |
Provided herein are quinoline, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of an endoplasmic reticulum stress-caused disease. Also provided herein are methods of their use for reducing endoplasmic reticulum stress and modulating the activity of a sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787767-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211839-A1 |
priorityDate |
2015-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |